These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24590691)

  • 1. Transforming growth factor-beta and its implication in the malignancy of gliomas.
    Roy LO; Poirier MB; Fortin D
    Target Oncol; 2015 Mar; 10(1):1-14. PubMed ID: 24590691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
    Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
    J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor.
    Jennings MT; Hart CE; Commers PA; Whitlock JA; Martincic D; Maciunas RJ; Moots PL; Shehab TM
    J Neurooncol; 1997 Feb; 31(3):233-54. PubMed ID: 9049853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
    Ashley DM; Kong FM; Bigner DD; Hale LP
    Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.
    Wick W; Platten M; Weller M
    J Neurooncol; 2001 Jun; 53(2):177-85. PubMed ID: 11716069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1.
    Merzak A; McCrea S; Koocheckpour S; Pilkington GJ
    Br J Cancer; 1994 Aug; 70(2):199-203. PubMed ID: 8054266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β Signaling Promotes Glioma Progression Through Stabilizing Sox9.
    Chao M; Liu N; Sun Z; Jiang Y; Jiang T; Xv M; Jia L; Tu Y; Wang L
    Front Immunol; 2020; 11():592080. PubMed ID: 33613515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
    Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
    Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF beta signaling and its role in glioma pathogenesis.
    Kaminska B; Kocyk M; Kijewska M
    Adv Exp Med Biol; 2013; 986():171-87. PubMed ID: 22879069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets.
    Song L; Liu L; Wu Z; Li Y; Ying Z; Lin C; Wu J; Hu B; Cheng SY; Li M; Li J
    J Clin Invest; 2012 Oct; 122(10):3563-78. PubMed ID: 23006329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of thrombospondin-1 in the activation of latent transforming growth factor-beta in malignant glioma cells.
    Sasaki A; Naganuma H; Satoh E; Kawataki T; Amagasaki K; Nukui H
    Neurol Med Chir (Tokyo); 2001 May; 41(5):253-8; discussion 258-9. PubMed ID: 11396305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of transforming growth factor beta in glioma progression.
    Jennings MT; Pietenpol JA
    J Neurooncol; 1998 Jan; 36(2):123-40. PubMed ID: 9525812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway.
    Tang F; Wang H; Chen E; Bian E; Xu Y; Ji X; Yang Z; Hua X; Zhang Y; Zhao B
    J Cell Physiol; 2019 Dec; 234(12):23302-23314. PubMed ID: 31140621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
    Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
    Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
    Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion.
    Coras R; Hölsken A; Seufert S; Hauke J; Eyüpoglu IY; Reichel M; Tränkle C; Siebzehnrübl FA; Buslei R; Blümcke I; Hahnen E
    Mol Cancer Ther; 2007 Jun; 6(6):1745-54. PubMed ID: 17541035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
    Yang X; Lv S; Zhou X; Liu Y; Li D; Shi R; Kang H; Zhang J; Xu Z
    Mol Neurobiol; 2015 Aug; 52(1):270-6. PubMed ID: 25148935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas.
    Stiles JD; Ostrow PT; Balos LL; Greenberg SJ; Plunkett R; Grand W; Heffner RR
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):435-9. PubMed ID: 9100674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of transforming growth factor-beta (TGF-beta) and epidermal growth factor (EGF) in human glioma cells.
    Held-Feindt J; Lütjohann B; Ungefroren H; Mehdorn HM; Mentlein R
    J Neurooncol; 2003 Jun; 63(2):117-27. PubMed ID: 12825816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
    Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
    Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.